
Kim Lab Publications:
- Assessment of Facial Morphologic Features in Patients with Congenital Adrenal Hyperplasia using Deep Learning
- Congenital Adrenal Hyperplasia in the Adolescent
- Increased Abdominal Adiposity in Adolescents and Young Adults With Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
- Decreased Adrenomedullary Function in Infants With Classical Congenital Adrenal Hyperplasia
- Low Adrenomedullary Function in Infancy Predicts Acute Illness in CAH
- Absence of Testicular Adrenal Rest Tumors in Newborns, Infants, and Toddlers with CAH
- Intima-Media Thickness Is Associated with Androgens in Adolescents/Young Adults with CAH
- Improved Medic-Alert Utilization in CAH
- Management of Congenital Adrenal Hyperplasia in Childhood
- Testicular Adrenal Rest Tumors in Boys and Young Adults
- Gray Matter Brain Differences in Youth with CAH
- White Matter Brain Differences in Youth with CAH
- No difference in 2D:4D between Youth with Prenatal Androgen Exposure due to Congenital Adrenal Hyperplasia and Controls
- Early Adiposity Rebound in Youth with Congenital Adrenal Hyperplasia Predicts Childhood Obesity and Adiposity in Adolescence
- Weight Loss Due to Topiramate in Adolescent with CAH
- Digit ratio (2D:4D) and congenital adrenal hyperplasia (CAH): Systematic literature review and meta-analysis.
- Majority of females with a life-long experience of CAH and parents do not consider females with CAH to be intersex
- Patients’ and Caregivers’ Attitudes toward ‘Disorders of Sex Development’ Nomenclature
- Developmental Changes in Food Perception and Preferences
- Brain Subregion Morphology Associated with Obesity and Dietary Self-Control
Additional CAH Publications of interest:
(CAH care guidelines from the Endocrine Society)
- Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline
- A Pharmacokinetic and Pharmacodynamic Study of Delayed and Extended Release Hydrocortisone (Chronocort™) versus Conventional Hydrocortisone (Cortef) in the Treatment of Congenital Adrenal Hyperplasia
- The Phenotypic Spectrum of Contiguous Deletion of CYP21A2 and Tenascin XB: Quadricuspid Aortic Valve and Other Midline Defects
- Clinical Characteristics of a Cohort of 244 Patients with Congenital Adrenal Hyperplasia
- Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.